Cassava Sciences, Inc.

NasdaqCM:SAVA

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 96.13 M

Share Price

USD 1.99

Avg Daily Volume

1,444,677

Change (1 day)

-3.86%

Change (1 year)

-90.04%

Change (YTD)

-15.68%

Cassava Sciences, Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: -15.68%

Cassava Sciences, Inc. Share Price Year-To-Date (YTD) return is -15.68% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Cassava Sciences, Inc. 52-week low Share Price is USD 35.08 on June 20, 2025, which is 1,662.81% above the current Share Price.
Cassava Sciences, Inc. 52-week low Share Price is USD 1.19 on June 20, 2025, which is -40.20% below the current Share Price.
Cassava Sciences, Inc. average Share Price for the last 52 weeks is USD 11.80.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NasdaqCM: SAVA

Cassava Sciences, Inc.

CEO	Mr. Richard Jon Barry
IPO Date	July 14, 2000
Location	United States
Headquarters	7801 North Capital of Texas Highway
Employees	30
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 💊 Pharmaceuticals

Description

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.